Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast


#1372481

187pages

Renub Research

$ 1999

In Stock

Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2 components: glucose sensors and CGM transmitters. Transmitters & receivers along with sensors are known as standalone CGM systems, which are preinstalled by manufacturer. Sensors are disposable items, which is replaced after every 5-7 days. By geography, this market is studied with respect to major Industrialized Countries (United States, United Kingdom, Israel, Germany, France, Netherlands, Sweden, Switzerland, Australia, Japan and Canada).

United States has the Highest CGM Market Globally 

CGM (Continuous Glucose Monitor) is extremely relevant to almost all age groups to manage diabetes efficiently and effectively. United States controls the global CGM Market. In Europe Germany and France CGM market has grown to a noticeable strength. According to many experts CGM is the best device for proper diabetes management for those having severe diabetes complications occurred periodically.

Countries Specific CGM Reimbursement details are covered in this Report

CGM reimbursement is still in its infancy stages in many countries but policy has been expanding over a period of time and addition of technological device under diabetes management is implemented by many countries. At present CGM is reimbursed for pediatric, gestational diabetes and Type 1 diabetes patients in some countries and it is expected that it will be accessible to all diabetes patients in due course of time. As countries are continuously expanding their diabetes management policy and several positive assessments are being done in favor of CGM it is expected to drive the market in future.

Renub Research latest study “Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Global CGM Market. This 187 page report with 163 Figures and 4 Tables studies the

Continuous Glucose Monitoring (CGM) market from 3 view points:  

  • CGM Market
  • CGM Users
  • CGM Reimbursements Policy

Scope of the Report

  • CGM Market & Forecast: We have defined CGM market of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024
  • CGM Users & Forecast: We have defined CGM number of Users of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024
  • Reimbursement Policy: Report provides Reimbursement Policy on CGM for 11 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model
  • Diabetes Population: Report covers 11 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast
  • Growth Factors for CGM: This topic studies the factors which is helping the CGM industry to grow
  • Challenges for CGM: This industry shows the problems being faced by the CGM technology


Countries Covered

  1. United States
  2. Canada 
  3. Germany 
  4. Australia 
  5. France 
  6. Netherlands
  7. Switzerland
  8. Sweden 
  9. Israel 
  10. United Kingdom
  11. Japan

Key Questions Answered in the Report?   
 

  • What is the Global CGM Market & its growth forecast?  
  • What are the Global CGM Users & its growth forecast?
  • What is the CGM market & forecast in 11 countries globally? 
  • What is the CGM users & forecast in 11 countries globally? 
  • What is the CGM reimbursement policy in each of these 11 countries?

Table of Content

1. Executive Summary

2. Global – CGM User (2010 – 2024)

3. Global – CGM Market & Forecast (2010 – 2024)

4. By Components – CGM Market (2010 – 2024)
4.1 Glucose Sensor Market & Forecast
4.2 CGM Transmitter Market & Forecast

5. Market Share – By Countries

6. Global CGM (Continuous Glucose Monitoring) Reimbursement Model

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United States – Diabetes Population (2010 – 2024)
8.1 United States Total Diabetes Population
8.1.1 United States Type 1 Diabetes Population
8.1.2 United States Type 2 Diabetes Population

9. United States – CGM Market & Forecast
9.1 United States - CGM Market by Components
9.1.1 Glucose Sensor Market & Forecast
9.1.2 CGM Transmitter Market & Forecast

10. United States – CGM User (2010 – 2024)

11. CGM Reimbursement in United States

12. United Kingdom – Diabetes Population (2010 – 2024)
12.1 United Kingdom – Total Diabetes Population
12.1.1 United Kingdom Type 1 Diabetes Population
12.1.2 United Kingdom Type 2 Diabetes Population

13. United Kingdom - CGM Market & Forecast
13.1 United Kingdom - CGM Market by Components
13.1.1 Glucose Sensor Market & Forecast
13.1.2 CGM Transmitter Market & Forecast

14. United Kingdom – CGM User (2010 – 2024)

15. CGM Reimbursement in United Kingdom

16. Israel – Diabetes Population (2010 – 2024)
16.1 Israel – Total Diabetes Population & Forecast
16.1.1 Type 1 Diabetes Population
16.1.2 Type 2 Diabetes Population

17. Israel - CGM Market & Forecast
17.1 Israel - CGM Market by Components
17.1.1 Glucose Sensor Market & Forecast
17.1.2 CGM Transmitter Market & Forecast

18. Israel – CGM User (2010 – 2024)

19. CGM Reimbursement in Israel

20. Germany – Diabetes Population (2010 – 2024)
20.1 Germany – Total Diabetes Population
20.1.1 Type 1 Diabetes Population
20.1.2 Type 2 Diabetes Population

21. Germany - CGM Market & Forecast
21.1 Germany - CGM Market by Components
21.1.1 Glucose Sensor Market & Forecast
21.1.2 CGM Transmitter Market & Forecast

22. Germany – CGM User (2010 – 2024)

23. CGM Reimbursement in Germany

24. Netherlands – Diabetes Population (2010 – 2024)
24.1 Netherlands – Total Diabetes Population
24.1.1 Type 1 Diabetes Population
24.1.2 Type 2 Diabetes Population

25. Netherlands - CGM Market & Forecast
25.1 Netherlands - CGM Market by Components
25.1.1 Glucose Sensor Market & Forecast
25.1.2 CGM Transmitter Market & Forecast

26. Netherlands – CGM User (2010 – 2024)

27. CGM Reimbursement in Netherlands

28. Sweden – Diabetes Population (2010 – 2024)
28.1 Sweden – Total Diabetes Population & Forecast
28.1.1 Type 1 Diabetes Population
28.1.2 Type 2 Diabetes Population

29. Sweden - CGM Market & Forecast
29.1 Sweden – CGM Market by Components
29.1.1 Glucose Sensor Market & Forecast
29.1.2 CGM Transmitter Market & Forecast

30. Sweden – CGM User (2010 – 2024)

31. CGM Reimbursement in Sweden

32. France – Diabetes Population (2010 – 2024)
32.1 France – Diabetes Population
32.1.1 Type 1 Diabetes Population
32.1.2 Type 2 Diabetes Population

33. France - CGM Market & Forecast
33.1 France - CGM Market by Components
33.1.1 Glucose Sensor Market & Forecast
33.1.2 CGM Transmitter Market & Forecast

34. France – CGM User (2010 – 2024)

35. CGM Reimbursement in France

36. Switzerland – Diabetes Population (2010 – 2024)
36.1 Switzerland – Total Diabetes Population
36.1.1 Type 1 Diabetes Population
36.1.2 Type 2 Diabetes Population

37. Switzerland - CGM Market & Forecast
37.1 Switzerland - CGM Market by Components
37.1.1 Glucose Sensor Market & Forecast
37.1.2 CGM Transmitter Market & Forecast

38. Switzerland – CGM User (2010 – 2024)

39. CGM Reimbursement in Switzerland

40. Australia – Diabetes Population (2010 – 2024)
40.1 Australia – Total Diabetes Population
40.1.1 Type 1 Diabetes Population
40.1.2 Type 2 Diabetes Population

41. Australia - CGM Market & Forecast
41.1 Australia - CGM Market by Components
41.1.1 Glucose Sensor Market & Forecast
41.1.2 CGM Transmitter Market & Forecast

42. Australia – CGM User (2010 – 2024)

43. CGM Reimbursement in Australia

44. Japan – Diabetes Population (2010 – 2024)
44.1 Japan – Total Diabetes Population
44.1.1 Type 1 Diabetes Population
44.1.2 Type 2 Diabetes Population

45. Japan - CGM Market & Forecast
45.1 Japan - CGM Market by Components
45.1.1 Japan – Glucose Sensor Market & Forecast
45.1.2 Japan – CGM Transmitter Market & Forecast

46. Japan – CGM User (2010 – 2024)

47. CGM Reimbursement in Japan

48. Canada – Diabetes Population (2010 – 2024)
48.1 Canada Diabetes Population
48.1.1 Type 1 Diabetes Population
48.1.2 Type 2 Diabetes Population

49. Canada - CGM Market & Forecast
49.1 Canada - CGM Market by Components
49.1.1 Glucose Sensor Market & Forecast
49.1.2 CGM Transmitter Market & Forecast

50. Canada – CGM User (2010 – 2024)

51. CGM Reimbursement in Canada

52. Market Dynamics
52.1 Growth Drivers
52.1.1 Continuous Positive Cost Effective Analysis by Several Countries
52.1.2 CGM Technology Convenient for both Patients & Physicians
52.2 Challenges
52.2.1 Controversy regarding Clinical Benefits

Table 3?1: Global – CGM Market Share (Percent), 2010 – 2016
Table 3?2: Global – Forecast for CGM Market Share (Percent), 2017 – 2024
Table 6?1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017
Table 7?1: Abbott Freestyle Libre vs. CGM
 

Figure 2?1: Global – CGM User (Number), 2010 – 2016
Figure 2?2: Global – Forecast for CGM User (Number), 2017 – 2024
Figure 3?1: Global – CGM Market (Million US$), 2010 – 2016
Figure 3?2: Global – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 4?1: Global – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 4?2: Global – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 4?3: Global – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 4?4: Global – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 7?1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017
Figure 8?1: United States – Diabetes Population (Thousand), 2010 - 2016
Figure 8?2: United States – Forecast for Diabetes Population (Thousand), 2017 - 2024
Figure 8?3: United States – Type 1 Diabetes Population (Thousand), 2010 - 2016
Figure 8?4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
Figure 8?5: United States: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 8?6: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 9?1: United States – CGM Market (Million US$), 2010 – 2016
Figure 9?2: United States – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 9?3: United States – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 9?4: United States – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 9?5: United States – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 9?6: United States – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 10?1: United States – CGM User (Number), 2010 – 2016
Figure 10?2: United States – Forecast for CGM User (Number), 2017 – 2024
Figure 12?1: United Kingdom: Diabetes Population (Thousand), 2010 – 2016
Figure 12?2: United Kingdom: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 12?3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 12?4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 12?5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 12?6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 13?1: United Kingdom – CGM Market (Million US$), 2010 – 2016
Figure 13?2: United Kingdom – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 13?3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 13?4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 13?5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 13?6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 14?1: United Kingdom – CGM User (Number), 2010 – 2014
Figure 14?2: United Kingdom – Forecast for CGM User (Number), 2017 – 2024
Figure 16?1: Israel: Diabetes Population (Thousand), 2010 – 2016
Figure 16?2: Israel: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 16?3: Israel: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 16?4: Israel: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 16?5: Israel: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 16?6: Israel: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 17?1: Israel – CGM Market (Million US$), 2010 – 2016
Figure 17?2: Israel – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 17?3: Israel – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 17?4: Israel – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 17?5: Israel – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 17?6: Israel – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 18?1: Israel – CGM User (Number), 2010 – 2016
Figure 18?2: Israel – Forecast for CGM User (Number), 2017 – 2024
Figure 20?1: Germany: Diabetes Population (Thousand), 2010 – 2016
Figure 20?2: Germany: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 20?3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 20?4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 20?5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 20?6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 21?1: Germany – CGM Market (Million US$), 2010 – 2016
Figure 21?2: Germany – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 21?3: Germany – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 21?4: Germany – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 21?5: Germany – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 21?6: Germany – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 22?1: Germany – CGM User (Number), 2010 – 2016
Figure 22?2: Germany – Forecast for CGM User (Number), 2017 – 2024
Figure 24?1: Netherlands: Diabetes Population (Thousand), 2010 – 2016
Figure 24?2: Netherlands: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 24?3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 24?4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 24?5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 24?6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 25?1: Netherlands – CGM Market (Million US$), 2010 – 2016
Figure 25?2: Netherlands – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 25?3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 25?4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 25?5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 25?6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 26?1: Netherlands – CGM User (Number), 2010 – 2016
Figure 26?2: Netherlands – Forecast for CGM User (Number), 2017 – 2024
Figure 28?1: Sweden: Diabetes Population (Thousand), 2010 – 2016
Figure 28?2: Sweden: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 28?3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 28?4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 28?5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 28?6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 29?1: Sweden – CGM Market (Million US$), 2010 – 2016
Figure 29?2: Sweden – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 29?3: Sweden – Glucose Sensor Market (Million US$), 2010 -2016
Figure 29?4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2017 -2024
Figure 29?5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 29?6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 30?1: Sweden – CGM User (Number), 2010 – 2016
Figure 30?2: Sweden – Forecast for CGM User (Number), 2017 – 2024
Figure 32?1: France – Diabetes Population (Thousand), 2010 – 2016
Figure 32?2: France – Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 32?3: France – Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 32?4: France – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 32?5: France – Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 32?6: France – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 33?1: France – CGM Market (Million US$), 2010 – 2016
Figure 33?2: France – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 33?3: France – Glucose Sensor Market (Million), 2010 – 2016
Figure 33?4: France – Forecast for Glucose Sensor Market (Million), 2017 – 2024
Figure 33?5: France – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 33?6: France – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 34?1: France – CGM User (Number), 2010 -2016
Figure 34?2: France – Forecast for CGM User (Number), 2017 -2024
Figure 36?1: Switzerland: Diabetes Population (Thousand), 2010 – 2016
Figure 36?2: Switzerland: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 36?3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 36?4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 36?5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 36?6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 37?1: Switzerland – CGM Market (Million US$), 2010 – 2016
Figure 37?2: Switzerland – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 37?3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 37?4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 37?5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 37?6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 38?1: Switzerland – CGM User (Number), 2010 – 2016
Figure 38?2: Switzerland – Forecast for CGM User (Number), 2017 – 2024
Figure 40?1: Australia: Diabetes Population (Thousand), 2010 – 2016
Figure 40?2: Australia: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 40?3: Australia: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 40?4: Australia: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 40?5: Australia: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 40?6: Australia: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 41?1: Australia – CGM Market (Million US$), 2010 – 2016
Figure 41?2: Australia – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 41?3: Australia – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 41?4: Australia – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 41?5: Australia – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 41?6: Australia – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 42?1: Australia – CGM User (Number), 2010 – 2016
Figure 42?2: Australia – Forecast for CGM User (Number), 2017 – 2024
Figure 44?1: Japan: Diabetes Population (Thousand), 2010 – 2016
Figure 44?2: Japan: Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 44?3: Japan: Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 44?4: Japan: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 44?5: Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 44?6: Japan: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 45?1: Japan – CGM Market (Million US$), 2010 – 2016
Figure 45?2: Japan – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 45?3: Japan – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 45?4: Japan – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 45?5: Japan – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 45?6: Japan – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 46?1: Japan – CGM User (Number), 2010 – 2016
Figure 46?2: Japan – Forecast for CGM User (Number), 2017 – 2024
Figure 48?1: Canada – Diabetes Population (Thousand), 2010 – 2016
Figure 48?2: Canada – Forecast for Diabetes Population (Thousand), 2017 – 2024
Figure 48?3: Canada – Type 1 Diabetes Population (Thousand), 2010 – 2016
Figure 48?4: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
Figure 48?5: Canada – Type 2 Diabetes Population (Thousand), 2010 – 2016
Figure 48?6: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024
Figure 49?1: Canada – CGM Market (Million US$), 2010 – 2016
Figure 49?2: Canada – Forecast for CGM Market (Million US$), 2017 – 2024
Figure 49?3: Canada – Glucose Sensor Market (Million US$), 2010 – 2016
Figure 49?4: Canada – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
Figure 49?5: Canada – CGM Transmitter Market (Million US$), 2010 – 2016
Figure 49?6: Canada – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024
Figure 50?1: Canada – CGM User (Number), 2010 – 2016
Figure 50?2: Canada – Forecast for CGM User (Number), 2017 – 2024